Nulojix Injection, Powder, Lyophilized, For Solution
NDC 0003-0371
Product Information
Nulojix (belatacept) is a BLA-approved product labeled by E.r. Squibb & Sons, L.l.c.. Belatacept is used to help prevent organ rejection in people who have received a kidney transplant. It is supplied as a injection, powder, lyophilized, for solution for intravenous administration. This product entry covers the primary NDC 0003-0371 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 0003-0371?
What are the uses of this product?
What are Active Ingredients of this product?
- BELATACEPT 250 mg/1 - A fusion protein immunoconjugate of the extracellular domain of CTLA4 and the Fc domain of human IgG1. It functions as a T-cell co-stimulation blocker that inhibits TNF-ALPHA and prevents the activation of T-LYMPHOCYTES. It is used in the treatment of RHEUMATOID ARTHRITIS.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- BELATACEPT (UNII: E3B2GI648A)
- BELATACEPT (UNII: E3B2GI648A) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE (UNII: 593YOG76RN)
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- SUCROSE (UNII: C151H8M554)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1112976 - belatacept 250 MG Injection
- RxCUI: 1112980 - Nulojix 250 MG Injection
- RxCUI: 1112980 - belatacept 250 MG Injection [Nulojix]
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.
Patient Education
Belatacept Injection
Belatacept injection is used in combination with other medications to prevent rejection (attack of a transplanted organ by the immune system of a person receiving the organ) of kidney transplants. Belatacept injection is in a class of medications called immunosuppressants. It works by decreasing the activity of the immune system to prevent it from attacking the transplanted kidney.
[Learn More]
* Please review the full disclaimer at the bottom of this page.